ALZpath, Inc.
PrivateLast Round
Seed Round
Jul 21, 2026
Total Funding Raised
$1.9M
Company Overview
ALZpath, Inc. is a biotechnology company that develops diagnostic tools and solutions for Alzheimer's disease, centered around its proprietary pTau217 antibody for blood-based testing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ALZpath, Inc. Comparables
Compare ALZpath, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AgenT | 79% | |
| C2N Diagnostics | 77% | |
| Veravas | 77% | |
ALZpath, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jul 21, 2026 | ||||
| Seed | Jul 18, 2023 |
ALZpath, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| StartUp Health | Seed |
| Stead Impact Ventures and Foundation | Seed |
| Alzheimer's Drug Discovery Foundation | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 22, 2026
Monthly visitors increased 133% MoM, reaching 3.5K.
- Jan 5, 2026
Monthly visitors increased 75% MoM.
ALZpath, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ALZpath, Inc.'s valuation, stock price, and market status.